| Title |
Chemotherapy for metastatic and recurrent cervical cancer
|
|---|---|
| Published in |
Cochrane database of systematic reviews, October 2012
|
| DOI | 10.1002/14651858.cd006469.pub2 |
| Pubmed ID | |
| Authors |
Kate Scatchard, Jennifer L Forrest, Maxine Flubacher, Paul Cornes, Chris Williams |
| Abstract |
Cervical cancer is the second most common cancer among women up to 65 years of age and is the most frequent cause of death from gynaecological cancers worldwide. A woman's risk of developing cervical cancer by 65 years of age ranges from 0.69% in developed countries to 1.38% in developing countries. Although screening by Pap smear should mean early detection at a curable stage for most women, many still present with advanced or metastatic disease with a worse prognosis. The addition of platinum-based chemotherapy to radiotherapy has improved outcome compared to radiotherapy alone; however, 30% to 50% fail to respond to treatment or develop recurrent disease. There are no standard treatment options for these patients, although platinum-based chemotherapy is frequently used and trials are on-going. |
Mendeley readers
The data shown below were compiled from readership statistics for 224 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Ecuador | 1 | <1% |
| Belgium | 1 | <1% |
| Unknown | 221 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 28 | 13% |
| Researcher | 27 | 12% |
| Student > Ph. D. Student | 21 | 9% |
| Student > Bachelor | 21 | 9% |
| Student > Postgraduate | 15 | 7% |
| Other | 43 | 19% |
| Unknown | 69 | 31% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 85 | 38% |
| Biochemistry, Genetics and Molecular Biology | 16 | 7% |
| Nursing and Health Professions | 16 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 5 | 2% |
| Agricultural and Biological Sciences | 4 | 2% |
| Other | 24 | 11% |
| Unknown | 74 | 33% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 July 2017.
All research outputs
#16,784,715
of 25,461,852 outputs
Outputs from Cochrane database of systematic reviews
#10,726
of 12,090 outputs
Outputs of similar age
#123,041
of 193,450 outputs
Outputs of similar age from Cochrane database of systematic reviews
#203
of 244 outputs
Altmetric has tracked 25,461,852 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,090 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 38.2. This one is in the 10th percentile – i.e., 10% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 193,450 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 244 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.